About Neximmune (NEXI)
NexImmune, Inc is a clinical-stage biotechnology company. The Company is engaged in developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. The Company provide... Read more
- USD3.17
- USD3.37
- USD3.06
- USD28.69
- -45.60%
- --
- 6.91k
- 39.73k
- 5M
- 1.25
- -67.80%
Stock News
yesterday
Here's how Caitlin Clark's $338,000 WNBA contract compares to No. 1 picks from the NFL, NBA and MLB
CNBC
yesterday
Nordstrom family tries again to take department store private, forms special committee
CNBC
yesterday
Netflix forces Wall Street to focus on profit and revenue with decision to stop reporting subscriber numbers in 2025
CNBC
yesterday
A 'deeply misguided' political belief is weakening the economy, says Secretary of Commerce Gina Raimondo
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
